Literature DB >> 27660698

Diabetes mellitus and cognitive impairments.

Elham Saedi1, Mohammad Reza Gheini1, Firoozeh Faiz1, Mohammad Ali Arami1.   

Abstract

There is strong evidence that diabetes mellitus increases the risk of cognitive impairment and dementia. Insulin signaling dysregulation and small vessel disease in the base of diabetes may be important contributing factors in Alzheimer's disease and vascular dementia pathogenesis, respectively. Optimal glycemic control in type 1 diabetes and identification of diabetic risk factors and prophylactic approach in type 2 diabetes are very important in the prevention of cognitive complications. In addition, hypoglycemic attacks in children and elderly should be avoided. Anti-diabetic medications especially Insulin may have a role in the management of cognitive dysfunction and dementia but further investigation is needed to validate these findings.

Entities:  

Keywords:  Alzheimer’s disease; Cognitive disorders; Dementia; Diabetes; Insulin

Year:  2016        PMID: 27660698      PMCID: PMC5027005          DOI: 10.4239/wjd.v7.i17.412

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  75 in total

1.  Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.

Authors:  Konrad Talbot; Hoau-Yan Wang; Hala Kazi; Li-Ying Han; Kalindi P Bakshi; Andres Stucky; Robert L Fuino; Krista R Kawaguchi; Andrew J Samoyedny; Robert S Wilson; Zoe Arvanitakis; Julie A Schneider; Bryan A Wolf; David A Bennett; John Q Trojanowski; Steven E Arnold
Journal:  J Clin Invest       Date:  2012-04       Impact factor: 14.808

2.  Diabetes mellitus and progression of vascular brain lesions and brain atrophy in patients with symptomatic atherosclerotic disease. The SMART-MR study.

Authors:  Minke Kooistra; Mirjam I Geerlings; Willem P T M Mali; Koen L Vincken; Yolanda van der Graaf; Geert Jan Biessels
Journal:  J Neurol Sci       Date:  2013-07-06       Impact factor: 3.181

Review 3.  A systematic review of the association of diabetic retinopathy and cognitive impairment in people with Type 2 diabetes.

Authors:  R Crosby-Nwaobi; S Sivaprasad; A Forbes
Journal:  Diabetes Res Clin Pract       Date:  2011-12-09       Impact factor: 5.602

Review 4.  Cardiovascular outcomes in trials of oral diabetes medications: a systematic review.

Authors:  Elizabeth Selvin; Shari Bolen; Hsin-Chieh Yeh; Crystal Wiley; Lisa M Wilson; Spyridon S Marinopoulos; Leonard Feldman; Jason Vassy; Renee Wilson; Eric B Bass; Frederick L Brancati
Journal:  Arch Intern Med       Date:  2008-10-27

5.  Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model.

Authors:  Xu Wang; Wei Zheng; Jing-Wei Xie; Tao Wang; Si-Ling Wang; Wei-Ping Teng; Zhan-You Wang
Journal:  Mol Neurodegener       Date:  2010-11-02       Impact factor: 14.195

6.  Retinal microvascular abnormalities and cognitive decline: the ARIC 14-year follow-up study.

Authors:  S R Lesage; T H Mosley; T Y Wong; M Szklo; D Knopman; D J Catellier; S R Cole; R Klein; J Coresh; L H Coker; A R Sharrett
Journal:  Neurology       Date:  2009-09-15       Impact factor: 9.910

7.  Relation of diabetes to mild cognitive impairment.

Authors:  José A Luchsinger; Christiane Reitz; Bindu Patel; Ming-Xin Tang; Jennifer J Manly; Richard Mayeux
Journal:  Arch Neurol       Date:  2007-04

8.  High connectivity between reduced cortical thickness and disrupted white matter tracts in long-standing type 1 diabetes.

Authors:  Daniel T Franc; Christopher T Kodl; Bryon A Mueller; Ryan L Muetzel; Kelvin O Lim; Elizabeth R Seaquist
Journal:  Diabetes       Date:  2010-10-27       Impact factor: 9.461

Review 9.  Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer's disease.

Authors:  Natalia N Nalivaeva; Nikolai D Belyaev; Caroline Kerridge; Anthony J Turner
Journal:  Front Aging Neurosci       Date:  2014-09-17       Impact factor: 5.750

10.  Glycemic status and brain injury in older individuals: the age gene/environment susceptibility-Reykjavik study.

Authors:  Jane S Saczynski; Sigurdur Siggurdsson; Palmi V Jonsson; Gudny Eiriksdottir; Elin Olafsdottir; Olafur Kjartansson; Tamara B Harris; Mark A van Buchem; Vilmundur Gudnason; Lenore J Launer
Journal:  Diabetes Care       Date:  2009-06-09       Impact factor: 19.112

View more
  45 in total

1.  [Nicorandil improves cognitive dysfunction in mice with streptozotocin-induced diabetes].

Authors:  Wen-Hui Yan; Chun-Xi Zhang; Tong Xing; Xue Gong; Yu-Xuan Yang; Yi-Nuo Li; Xuan Liu; Jiamaliding Ayijiang; Ye Yu; Meng Zhang; Li-Na Chen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-04-20

2.  Dementia-like pathology in type-2 diabetes: A novel microRNA mechanism.

Authors:  Anuradha Kalani; Pankaj Chaturvedi; Claudio Maldonado; Philip Bauer; Irving G Joshua; Suresh C Tyagi; Neetu Tyagi
Journal:  Mol Cell Neurosci       Date:  2017-02-20       Impact factor: 4.314

3.  Cognitive and socio-cognitive functioning of chronic non-medical prescription opioid users.

Authors:  Sara L Kroll; Emilija Nikolic; Franziska Bieri; Michael Soyka; Markus R Baumgartner; Boris B Quednow
Journal:  Psychopharmacology (Berl)       Date:  2018-10-11       Impact factor: 4.530

4.  Effect of coenzyme Q10 supplementation on diabetes induced memory deficits in rats.

Authors:  Ghazaleh Omidi; Seyed Asaad Karimi; Arezoo Rezvani-Kamran; Amirreza Monsef; Siamak Shahidi; Alireza Komaki
Journal:  Metab Brain Dis       Date:  2019-03-08       Impact factor: 3.584

5.  Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease.

Authors:  Ramon Velazquez; An Tran; Egide Ishimwe; Larry Denner; Nikhil Dave; Salvatore Oddo; Kelly T Dineley
Journal:  Neurobiol Aging       Date:  2017-06-17       Impact factor: 4.673

6.  An Analysis into Metacognition and Family History of Diabetes Mellitus among First Year Medical Students.

Authors:  Ak Sunitha Priya; Rose Babu; Pallavi Panchu; Biju Bahuleyan
Journal:  J Clin Diagn Res       Date:  2017-07-01

Review 7.  The Increase of HIV-1 Infection, Neurocognitive Impairment, and Type 2 Diabetes in The Rio Grande Valley.

Authors:  Roberto De La Garza; Hansapani Rodrigo; Francisco Fernandez; Upal Roy
Journal:  Curr HIV Res       Date:  2019       Impact factor: 1.581

8.  EEG spectral power abnormalities and their relationship with cognitive dysfunction in patients with Alzheimer's disease and type 2 diabetes.

Authors:  Christopher S Y Benwell; Paula Davila-Pérez; Peter J Fried; Richard N Jones; Thomas G Travison; Emiliano Santarnecchi; Alvaro Pascual-Leone; Mouhsin M Shafi
Journal:  Neurobiol Aging       Date:  2019-10-14       Impact factor: 4.673

9.  Advanced glycation end-products disrupt brain microvascular endothelial cell barrier: The role of mitochondria and oxidative stress.

Authors:  Anthony Dobi; Sarah Rosanaly; Anne Devin; Pascal Baret; Olivier Meilhac; G Jean Harry; Christian Lefebvre d'Hellencourt; Philippe Rondeau
Journal:  Microvasc Res       Date:  2020-10-17       Impact factor: 3.514

10.  Neuromodulatory effects of green coffee bean extract against brain damage in male albino rats with experimentally induced diabetes.

Authors:  Ashraf Al-Brakati; Alaa Jameel A Albarakati; Hamid M A Daabo; Roua S Baty; Fatma Elzahraa H Salem; Ola A Habotta; Ehab K Elmahallawy; Doaa M Abdel-Mohsen; Heba Taha; Ahmed M A Akabawy; Rami B Kassab; Ahmed E Abdel Moneim; Hatim K Amin
Journal:  Metab Brain Dis       Date:  2020-06-16       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.